Farmacosmo S.p.A. (BIT:COSMO)
Italy
· Delayed Price · Currency is EUR 0.415
+0.009 (2.22%)
At close: Dec 5, 2025
Farmacosmo Revenue
Farmacosmo had revenue of 28.21M EUR in the half year ending June 30, 2025, a decrease of -24.48%. This brings the company's revenue in the last twelve months to 59.23M, down -13.09% year-over-year. In the year 2024, Farmacosmo had annual revenue of 64.10M, down -11.51%.
Revenue (ttm)
59.23M
Revenue Growth
-13.09%
P/S Ratio
0.27
Revenue / Employee
617.02K
Employees
95
Market Cap
16.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.10M | -8.34M | -11.51% |
| Dec 31, 2023 | 72.44M | 5.85M | 8.79% |
| Dec 31, 2022 | 66.59M | 8.09M | 13.83% |
| Dec 31, 2021 | 58.50M | 14.02M | 31.51% |
| Dec 31, 2020 | 44.48M | 20.17M | 82.96% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| DiaSorin | 1.21B |
| Amplifon | 2.41B |
| EL.En. | 580.41M |
| Philogen | 84.66M |
| Safilo Group | 998.89M |
| Pharmanutra | 127.15M |
| GPI S.p.A. | 531.42M |